 |
| |
| |
| Watch Cepheid's ECCMID 2024 Integrated Symposium Now |
| |
| “Innovating Rapid Molecular Diagnostics for Infectious Diseases: Real World Impact on Patient Care” |
| |
|
|
|
|
|
| |
|
It was wonderful to connect with so many members of the clinical microbiology and infectious diseases community at ECCMID 2024! In case you missed our symposium or would like to watch it again, you can access the on-demand recording at your convenience.
|
|
|
|
|
|
| |
| Chair: Dr. Beryl Oppenheim, Senior Director Medical Affairs, Cepheid, UK ESCMID-appointed Chair: Dr. Mariska Leeflang, Associate Professor, Amsterdam UMC, Netherlands |
|
|
| |
|
Speakers:
- Tristan Clark, Professor and Honorary Consultant in Infectious Diseases, University Hospital Southampton NHS Foundation Trust, UK
- Clemens Kill, Director, Center of Emergency Medicine Essen University, Germany
- Valeria Cento, Associate Professor of Microbiology, Humanitas Research Hospital, Italy
- Elena Reigadas, Microbiologist, Hospital General Universitario Gregorio Marañón, Spain
|
|
|
|
|
|
| |
| |
CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
|
|
 |
About Cepheid
|
| Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform advanced PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. |
| For more information, visit http://www.cepheid.com. |
|
|
| About Cepheid | Privacy Policy | Contact Us |
©2024 Cepheid. All Rights Reserved. |
| |
|
|
|
|
|
|
